{"nctId":"NCT00596466","briefTitle":"Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures","startDateStruct":{"date":"2008-04"},"conditions":["Epilepsy"],"count":75,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: pregabalin"]}],"interventions":[{"name":"pregabalin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Completed the previous protocol and wish to continue to receive pregabalin.\n* Diagnosis of epilepsy with partial seizures\n\nExclusion Criteria:\n\n* Early withdrawal from the previous protocol, an episode of status epliepticus, or primary generalized epilepsy.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Seizure Frequency","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"PRIMARY","title":"Number of Participants With (All Causality) Adverse Events (AEs) and Serious Adverse Events (SAEs)","description":"Counts of participants who had treatment-emergent adverse events (TEAEs), defined as newly occurring or worsening after first dose. Participants with multiple occurrences of an AE within a category were counted once within the category.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Laboratory Test Values of Potential Clinical Importance","description":"Pre-defined criteria were established for each laboratory test (hematology, blood chemistry and urinalysis) to define the values that would be identified as of potential clinical importance.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":73},"commonTop":["Nausea","Headache","Weight increased","Arthralgia","Convulsion"]}}}